ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
      QxMD      Google Scholar   
Citation:
Blood vol 118 (26) 6920-6929
Year:
2011
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
1
Parents:
467  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, P50 CA140158, CA140158, CA16058, CA101140, U10 CA077658, CA41287, U10 CA031946, R21 CA129657, U10 CA033601, U24 CA114725, U10 CA101140, U10 CA041287, P30 CA016058, CA77658, CA129657, CA114725, CA31946  
Corr. Author:
 
Authors:
                                           
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-20202, CALGB-8461, CALGB-9665
Phases:
N/A
Keywords:
Clinical Trials and Observations, Myeloid Neoplasia